Research: Brain Tumor Center of Excellence

The Brain Tumor Center of Excellence established several translational brain tumor research priorities, including:

• Discovery and development of new molecular anti-brain tumor therapies and their combination with other treatment modalities (Molecular Therapeutics Group)
• Understanding how radiation or other treatments may cause brain injury and how the improvement in the quality of life of patients undergoing various treatments can be achieved (Modulation of Treatment-induced Brain Injury/Quality of Life Group)
• Introduction of noninvasive means to image both normal brain and brain tumors at cellular and molecular levels, including damage evoked by and response to treatment (Bioanatomic Imaging Group) 
• Exploiting preclinical models offered by large animals, e.g., dogs with spontaneous tumors or nonhuman primates (NHPs) for studying cognitive functions (Pre-clinical Models of Disease Group, in continuously growing collaboration with Virginia Tech).